Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Feb 04, 2023 10:54am
346 Views
Post# 35266710

RE:RE:TLT is slowly starting to MOVE into that SWEET SPOT!

RE:RE:TLT is slowly starting to MOVE into that SWEET SPOT!


The JV will get us the funding soon and then and we will have BTD and AA and 9 other sites



Legit2 ... I don't know where you took that a jv is imminent as it is not.  It takes time to get in touch with all big pharmas. Have them reply, evaluate all offers received, have back and forth discussions, allow counter-offers, eliminate some, have lawyers on both side review final offer, etc ...  I once posted many examples of the transcripts of such negociations on biotech deals.  There are forms that must be rendered available to the investors and documented by Boards.

This is a lenghtly process that takes months. That's why TLT mentioned "throughout 2023-2024".

I don't think either that we would receive a hostile offer considering that no big pharma has PDT/PDC expertise.

In the meantime, it's the visibility of our clinical data that can act as eye openers for new serious investors like institutional funds in due time

 

<< Previous
Bullboard Posts
Next >>